ANTITUMOR-ACTIVITY OF QUINOCARMYCIN AGAINST CARCINOMA OF THE LUNG IN HUMAN-TUMOR CLONOGENIC-ASSAY

被引：14

作者：

CHIANG, C

KANZAWA, F

MATSUSHIMA, Y

NAKANO, H

NAKAGAWA, K

TAKAHASHI, H

TERADA, M

MORINAGA, S

TSUCHIYA, R

SASAKI, Y

SAIJO, N

机构：

[1] NATL CANC CTR HOSP,DIV PHARMACOL,1-1 TSUKIJI 5-CHOME,CHUO KU,TOKYO 104,JAPAN

[2] NATL CANC CTR HOSP,DIV PATHOL,TOKYO 104,JAPAN

[3] NATL CANC CTR HOSP,NATL CANC CTR RES INST,DIV SURG,TOKYO 104,JAPAN

[4] NATL CANC CTR HOSP,DEPT INTERNAL MED,TOKYO 104,JAPAN

[5] VET GEN HOSP,DEPT INTERNAL MED,DIV PULM MED,TAICHUNG 400,TAIWAN

来源：

JOURNAL OF PHARMACOBIO-DYNAMICS | 1987年 / 10卷 / 09期

关键词：

D O I：

10.1248/bpb1978.10.431

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

引用

页码：431 / 435

页数：5

共 14 条

[1]

AHMANN FR, 1982, CANCER RES, V42, P4495

[2]

ALBERTS DS, 1981, CANCER CHEMOTH PHARM, V6, P253

[3]

FUJIMOTO K, 1987, CANCER RES, V47, P1516

[4]

HUMAN-TUMOR CLONOGENIC-ASSAY FOR CARCINOMA OF THE LUNG .2. FACTORS THAT INFLUENCE COLONY FORMATION IN SOFT AGAR [J].

KANZAWA, F ;

MATSUSHIMA, Y ;

HAMBURGER, AW ;

ISHIHARA, J ;

SASAKI, Y ;

SHIMIZU, E ;

EGUCHI, K ;

SHINKAI, T ;

SAIJO, N ;

MIYAZAWA, N .

ONCOLOGY, 1987, 44 (03) :150-&

[5]

KANZAWA F, 1985, INVEST NEW DRUG, V3, P341

[6]

INVITRO CHEMOSENSITIVITY PATTERNS OF CARCINOMA OF THE LUNG IN HUMAN-TUMOR CLONOGENIC-ASSAY [J].

KANZAWA, F ;

MATSUSHIMA, Y ;

ISHIHARA, JI ;

SHIMIZU, E ;

SASAKI, Y ;

EGUCHI, K ;

SHINKAI, T ;

SAIJO, N ;

MIYAZAWA, N ;

HAMBURGER, AW .

JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (09) :715-721

[7]

MATSUSHIMA Y, 1986, ANTICANCER RES, V6, P921

[8]

TIME-SCHEDULE DEPENDENCY OF THE INHIBITING ACTIVITY OF VARIOUS ANTICANCER DRUGS IN THE CLONOGENIC-ASSAY [J].

MATSUSHIMA, Y ;

KANZAWA, F ;

HOSHI, A ;

SHIMIZU, E ;

NOMORI, H ;

SASAKI, Y ;

SAIJO, N .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (02) :104-107

[9]

SALMON SE, 1984, CANCER TREAT REP, V68, P117

[10]

SHIMIZU E, 1984, GANN, V75, P1030

← 1 2 →